celiprolol

FDA rejects Acer's rare disease drug, asks for new trial — shares crate
Endpoints
Wed, 06/26/19 - 10:11 am
Acer Therapeutics
celiprolol
hypertension
clinical trials
FDA
Ehlers-Danlos syndrome
Edsivo